214390 — Kyongbo Pharmaceutical Share News
0.000.00%
- KR₩123bn
- KR₩267bn
- KR₩264bn
Brief: Kyongbo Pharmaceutical Q3 Operating Profit 474 Million Won, Down 85% From Year Earlier
Brief: Kyongbo Pharmaceutical Q2 Operating Profit 2.4 Billion Won, Up 90% From Year Earlier
Brief: Kyongbo Pharmaceutical To Invest 85.5 Billion Won In Building Additional Factory
Brief: Kyongbo Pharmaceutical Q2 Operating Profit 1.3 Billion Won, Down 14.8% From Year Earlier
Brief: Kyongbo Pharmaceutical Q1 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Kyongbo Pharmaceutical Q3 Operating Profit 1.7 Billion Won, Swings To Profit From Year Earlier
Brief: Kyongbo Pharmaceutical Q1 Operating Loss 510 Million Won
Brief: Kyongbo Pharmaceutical Wins $7.5 Million Order
Brief: Kyongbo Pharmaceutical Terminates Supply Contract Worth $45 Mln Due To Non-Compliance With Contract Terms
S.Korean pharmaceutical firms surge on first confirmed case of coronavirus
Brief: Kyunbo Pharmaceutical Co Signs Contract Worth 57 Bln Won In Uzbekistan
Brief: AFT Pharmaceuticals Starts To License Maxigesic IV With Deal In South Korea
Brief: Kyongbo Pharmaceutical receives patent
Brief: Kyongbo Pharmaceutical says annual cash dividend for FY 2016
Brief: Kyongbo Pharmaceutical receives patent
Brief: Kyongbo Pharmaceutical receives patent
Brief: Kyongbo Pharmaceutical receives patent